抄録
A open trial study was performed to ascertain clinical efficacy and safety of Emorfazone for the treatment of inflammatory diseases in dental and oral surgery.
The following results were obtained:
1) The study was analysed in 44 patients.
2) The local symptoms of the specified 10 items impoved significantly both on the third and fifth day after the administration.
3) Rates of overall clinical effectiveness showing “excellent” and “good” were 39.5% on the first day, 67.6% on the third day and 80.6% on the fifth day after administration.
4) The rates of final overall effectiveness showed good and excellent were 65.9%.
5) Although side effects effects were found in 13.6% of 44 patients, most cases were not severe.
6) The overall usefulness showing “excellent” and “good” was 54.5%.
7) From the above rsults, Emorfazone was confirmed to be useful for treatment of inflammatory diseases in dental and oral surgery.
